focus -WSS

focus

author：fashion 2025-09-27 09:53:28 - browse：1935

The Amgen booth at ESMO in Madrid. Andrew Joseph/STAT

MADRID — A novel type of immunotherapy from Amgen generated strong response rates in patients with advanced small cell lung cancer, results that could lead to the approval of the drug.

The data, reported here Friday at the annual meeting of European Society for Medical Oncology, come from a Phase 2 trial of the drug, called tarlatamab. But they drew greater interest because Amgen has described the study as “potentially registrational,” and the trial results were also published Friday in the New England Journal of Medicine.

“It’s a single arm study, but the results are amazing,” said Silke Gillessen, the scientific chair of ESMO 2023 and an oncologist at the Oncology Institute of Southern Switzerland, noting that advances in small cell lung cancer have been slow to come.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Parkland mass shooting to be reenacted for lawsuit

WSS

Newly revealed memo details efforts to keep Trump in power following election loss

Maui funeral service workers on devastation of fires: 'I'm in shock'

CDC overhauls leadership of center that led response to Covid

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Listen: Your guide to Wegovy's blockbuster heart study

California Joshua trees severely burned in massive wildfire

hotspot

focus

leisure time

Continuity nursing helped my family in our darkest PICU moments

Climate activists disrupt London Pride march to protest corporate sponsorship

How to save PrEP access — and even expand it

Listen: Your guide to Wegovy's blockbuster heart study

Guidelines to prevent youth baseball injuries need more muscle

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Apple is now the first public company to be valued at $3 trillion

Newly revealed memo details efforts to keep Trump in power following election loss

At least 13 dead in Texas as scorching temps continue

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

focus

White House drug shortages task force keeps mum with Congress

Prosecutors seek bail revocation for FTX founder Sam Bankman

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Pharma needs to include young adults in clinical research

Slain Parkland victim's father speaks out following reenactment

Climate activists disrupt London Pride march to protest corporate sponsorship

knowledge

leisure time

entertainment

leisure time